NDTC
Executive Summary
Outgoing president of the National Wholesale Druggists Association Charles Trefrey is working on a special project for the upcoming meeting of the National Drug Trade Conference on Grand Cayman Island. To identify common positions among the associations, Trefrey has asked each participating association to prepare a two-three page paper setting out a vision for the future of their industry or profession and potential strategies for attaining their goals without impeding other segments of the health care system.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth